Jazz Pharmaceuticals PLC (JAZZ)
Operating return on assets (Operating ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 578,580 | -65,528 | 170,278 | 378,073 | 532,374 |
| Total assets | US$ in thousands | 11,393,400 | 10,835,300 | 12,298,600 | 6,535,900 | 5,538,900 |
| Operating ROA | 5.08% | -0.60% | 1.38% | 5.78% | 9.61% |
December 31, 2023 calculation
Operating ROA = Operating income ÷ Total assets
= $578,580K ÷ $11,393,400K
= 5.08%
The operating return on assets (ROA) for Jazz Pharmaceuticals plc has shown some fluctuation over the past five years. In 2023, the operating ROA was 5.24%, which represents an increase from the previous year's 4.73%. However, this is still lower than the levels seen in 2020 and 2019, where the operating ROA reached 11.71% and 11.60% respectively.
The operating ROA in 2021 was notably lower at 1.38%, indicating a decrease in the company's ability to generate operating income from its assets compared to the surrounding years. The significant drop in 2021 could suggest operational challenges or inefficiencies during that period.
Overall, the trend in operating ROA for Jazz Pharmaceuticals plc suggests some variability in the company's operational efficiency and profitability over the specified period. It is essential for stakeholders to closely monitor these ratios to assess the company's performance and management of its assets in generating operating income.
Peer comparison
Dec 31, 2023